Company / Cost of Revenue
MARIMED INC. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$101.9M
FY2025
5-year range
$55.2M / $101.9M
FY2021-FY2025
Trend
+7.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has increased for 5 consecutive years, from $20M in FY2020 to $102M in FY2025.
Based on SEC 10-K filings.
$102M in FY2025 with a 5-year CAGR of +39.1%.
Increased from $83M to $102M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +13.3%
- 5-Year CAGR
- +39.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- MARIMED INC.'s cost of revenue has grown for 5 consecutive years.
- 5-year CAGR of +39.1%, indicating consistent growth.
- In FY2025, cost of revenue increased 7.2% year-over-year.
- Lowest cost of revenue in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $101.9M | +7.2% |
| FY2024 | $95.1M | +15.0% |
| FY2023 | $82.7M | +18.0% |
| FY2022 | $70.1M | +26.9% |
| FY2021 | $55.2M | +182.1% |
| FY2020 | $19.6M | -27.3% |
| FY2019 | $26.9M | +565.7% |
| FY2018 | $4.0M | +84.3% |
| FY2017 | $2.2M | +62.2% |
| FY2016 | $1.4M | -13.7% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026